SCHEMBL3632825

SCHEMBL3632825

C=C(C(=O)NO)c1ccc2c(c1)nc(CCC1CCCC1)n2CCN1CCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 7/20 0.47
▸ HDAC8 Q9BY41 4/20 0.47
▸ HDAC6 Q9UBN7 3/20 0.47
▸ HDAC3 O15379 2/20 0.47
▸ HDAC4 P56524 2/20 0.47
▸ HDAC2 Q92769 2/20 0.47
▸ HDAC10 Q969S8 2/20 0.47
▸ HDAC11 Q96DB2 2/20 0.47
▸ HDAC9 Q9UKV0 2/20 0.47
▸ HDAC5 Q9UQL6 2/20 0.47
▸ BCHE P06276 2/20 0.41
▸ CNR2 P34972 1/20 0.41
▸ OPRM1 P35372 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3399930 0.84 HDAC6 (0.50) HDAC1HDAC6KDM4EKMT2AMEN1
SCHEMBL19732376 0.81 HDAC1 (0.52) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL8290488 0.80 HDAC1 (0.59) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL13118189 0.79 HDAC1 (0.73) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL8290490 0.79 HDAC1 (0.60) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL13226936 0.79 HDAC1 (0.74) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL3632827 0.76 HDAC1 (0.42) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL3372287 0.72 HDAC1 (0.55) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL3372282 0.72 HDAC1 (0.55) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL17075912 0.70 HDAC1 (0.65) HDAC1HDAC8HDAC6HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9402829-B2 Benzimidazole derivatives: preparation and pharmaceutical applications MEI PHARMA, INC. (US) 2016-08-02 — — US disclosed
US-20150157608-A1 BENZIMIDAZOLE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S*BIO PTE LTD. (SG) 2015-06-11 — — US disclosed
US-9024029-B2 Benzimidazole derivatives: preparation and pharmaceutical applications MEI PHARMA, INC. (US) 2015-05-05 — — US disclosed
US-20140005194-A1 BENZIMIDAZOLE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS MEI PHARMA, INC. (US) 2014-01-02 — — US disclosed
US-7781595-B2 Benzimidazole derivatives: preparation and pharmaceutical applications S*BIO PTE LTD. (SG) 2010-08-24 — — US disclosed
US-20070043043-A1 Benzimidazole derivates: preparation and pharmaceutical applications S*BIO PTE LTD. (SG) 2007-02-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043043-A1 Benzimidazole derivates: preparation and pharmaceutical applications HDAC5, HDAC1, HDAC4 HDAC1 2/4885HDAC8 4/4885HDAC6 10/4885
US-20140005194-A1 BENZIMIDAZOLE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS HDAC5, HDAC1, HDAC8 HDAC1 2/4885HDAC8 3/4885HDAC6 10/4885
US-20150157608-A1 BENZIMIDAZOLE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS HDAC5, HDAC1, HDAC8 HDAC1 2/4885HDAC8 3/4885HDAC6 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback